Risk Factors for Hypovitaminosis D in Nondialyzed Chronic Kidney Disease Patients

Journal of Renal Nutrition

Volumn 22, Issue 1, 2012, Pages 4-11

  Figuiredo Dias, Vilani ^a   Cuppari, Lilian ^a   Garcia Lopes, Miriam Ghedini ^a   de Carvalho, Aluízio Barbosa ^a   Draibe, Sergio Antonio ^a   Kamimura, Maria Ayako ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; PARATHYROID HORMONE; VITAMIN D;

ADULT; AGED; ARTICLE; BLOOD; BODY FAT DISTRIBUTION; BODY MASS; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN RESISTANCE; LUMINESCENCE; MALE; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; RISK FACTOR; SEASON; VITAMIN D DEFICIENCY;

ADULT; AGED; BODY FAT DISTRIBUTION; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIETARY SUPPLEMENTS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; LUMINESCENT MEASUREMENTS; MALE; MIDDLE AGED; OBESITY; PARATHYROID HORMONE; RISK FACTORS; SEASONS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84855186451     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2011.02.001     Document Type: Article

References (39)

1. Holick M.F. Vitamin D deficiency. Am N Engl J Med 2007, 357:266-281.
2. Heaney R.P. Vitamin D in health and disease. Am Clin J Am Soc Nephrol 2008, 3:1535-1541.
3. Chiu C.K., Chu A., Go V.L.W., et al. Hypovitaminosis D is associated with insulin resistance and cell dysfunction. Am J Clin Nutr 2004, 79:820-825.
4. Palomer X., González-Clemente J.M., Blanco-Vaca F., et al. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diab Obes Metab 2008, 10:185-197.
5. Ford E.S., Ajani U.A., McGuire L.C., et al. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005, 28:1228-1230.
6. Holick M.F. The influence of vitamin D on bone health across the life cycle. J Nutr 2005, 135:2726S-2727S.
7. Wortsman J., Matsuoka L.Y., Chen T.C., et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000, 72:690-693.
8. Pittas A.G., Lau J., Hu F.B., et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007, 2:2017-2029.
9. Cuppari L., Carvalho A.B., Draibe S.A. Vitamin D status of chronic kidney disease patients living in a sunny country. J Ren Nutr 2008, 18:408-414.
10. Mehrotra R., Kermah D., Budoff M., et al. Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol 2008, 3:1144-1151.
11. Gonzalez E.A., Sachdeva A., Oliver D.A., et al. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 2004, 24:503-510.
12. Del Valle E., Negri A.L., Aguirre C., et al. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis. Hemodial Int 2007, 11:315-321.
13. Shah N., Bernadini J., Piraino B. Prevalence and correction of 25(OH) vitamin D deficiency in peritoneal dialysis patients. Perit Dial Int 2005, 25:362-366.
14. Smith A.G., Shuster S., Comaish J.S., et al. Plasma immunoreactive beta-melanocyte-stimulating hormone and skin pigmentation in chronic renal failure. Br Med J 1975, 22:658-659.
15. Abdelbaqi-Salhab M., Shalhub S., Morgan M.B. A current review of the cutaneous manifestations of renal disease. J Cutan Pathol 2003, 30:527-538.
16. Jacob A.I., Sallman A., Santiz Z., et al. Defective photoproduction of cholecalciferol in normal and uremic humans. J Nutr 1984, 114:1313-1319.
17. Saha H. Calcium and vitamin D homeostasis in patients with heavy proteinuria. Clin Nephrol 1994, 41:290-296.
18. Kramer H., Tuttle K.R., Leehey D., et al. Obesity management in adults with CKD. Am J Kidney Dis 2009, 53:151-165.
19. Ravani P., Malberti F., Tripepi G., et al. Vitamin D levels andpatient outcome in chronic kidney disease. Kidney Int 2009, 75:88-95.
20. Mehrotra R., Kermah D.A., Salusky I.B., et al. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int 2009, 76:977-983.
21. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999, 130:461-470.
22. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and ß-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
23. Adequacy of dialysis and nutrition in continual peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996, 7:198-207. CANADA-USA (CANUSA) Peritoneal Dialysis Study Group.
24. Reportof a WHO Consultation on Obesity 1997, WHO preventing and managing the global epidemic, WHO, Geneva, Switzerland.
25. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003, 42:S1-S201.
26. Looker A.C. Body fat and vitamin D status in black versus white women. J Clin Endocrinol Metab 2005, 90:635-640.
27. Picó M.R., Lugo-Somolinos A., Sánchez J.L., et al. Cutaneous alterations in patients with chronic renal failure. Int J Dermatol 1992, 31:860-863.
28. Liu E., Meigs J.B., Pittas A.G., et al. Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 2009, 139:329-334.
29. Von Hurst P.R., Stonehouse W., Coad J. Vitamin D supplementation reduces insulin in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient- a randomised, placebo-controlled trial. Br J Nutr 2010, 103:549-555.
30. De Boer I. Vitamin D and glucose metabolism in chronic kidney disease. Curr Opin Nephrol Hypertens 2008, 17:566-572.
31. Agarwal R. Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD. J Am Soc Nephrol 2009, 4:1523-1528.
32. Bouillon R., Carmeliet G., Verlinden L., et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008, 29:726-776.
33. Sato K.A., Gray R.W., Lemann J. Urinary excretion of 25-hydroxyvitamin D in health and the nephrotic syndrome. J Lab Clin Med 1982, 99:325-330.
34. Vilarrasa N., Maravall J., Estepa A., et al. Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables. J Endocrinol Invest 2007, 30:653-658.
35. Arunabh S., Pollack S., Yeh J., et al. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 2003, 88:157-161.
36. Lumb G.A., Mawer E.B., Stanbury S.W. The apparent vitamin D resistance of chronic renal failure: a study of the physiology of vitamin D in man. Am J Med 1971, 50:421-444.
37. Bell N.H., Epstein S., Greene A., et al. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 1985, 76:370-373.
38. Tzotzas T., Papadopoulou F.G., Tziomalos K., et al. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. J Clin Endocrinol Metab 2010, 95:4251-4257.
39. Reinehr T., de Sousa G., Alexy U., et al. Vitamin D status and parathyroid hormone in obese children before and after weight loss. Eur J Endocrinol 2007, 157:225-232.